Skip to main content
Improve Medical Instruments CO., Ltd. logo

Improve Medical Instruments CO., Ltd. — Investor Relations & Filings

Ticker · 300030 ISIN · CNE100000JL3 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,954 across all filing types
Latest filing 2020-02-12 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300030

About Improve Medical Instruments CO., Ltd.

https://www.improve-medical.com

Improve Medical Instruments CO., Ltd. focuses on the development, production, and distribution of clinical laboratory and nursing solutions. The core product range includes evacuated blood collection systems, specimen collection and transport media, and laboratory automation equipment. The company also provides medical imaging components and point-of-care testing (POCT) systems. By integrating research and development with advanced manufacturing, the organization supports clinical diagnostics and patient care through high-precision tools designed for healthcare facilities and research laboratories. Its offerings are characterized by a commitment to diagnostic safety and efficiency across global markets.

Recent filings

Filing Released Lang Actions
关于子公司变更医疗器械生产许可证的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement from Guangzhou Yangpu Medical Technology Co., Ltd. regarding a change in the medical device production license of its subsidiary. It details the updated license information, including the addition of a new product (sterile medical protective masks) to the production scope. The document is short (1146 characters) and serves as an official notification about a regulatory update rather than a financial report or detailed management discussion. It does not contain financial data, earnings, or management commentary. It is not a report itself but an announcement of a regulatory change. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2020-02-12 Chinese
股价异动的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement from Guangzhou Yangpu Medical Technology Co., Ltd. regarding abnormal stock price fluctuations. It explains the situation, the company's investigation, and clarifies that no undisclosed material information exists that could have caused the stock price movement. It also discusses the impact of the COVID-19 pandemic on the company's operations and products. The document is short (2008 characters) and serves as a regulatory disclosure about stock price abnormality and related risk factors. It does not contain financial statements, detailed financial analysis, or management discussion of results. It is not an annual or interim report, earnings release, or any other detailed financial report. It is a regulatory announcement about stock price movement and company disclosures, fitting the category of Regulatory Filings (RNS).
2020-02-11 Chinese
关于子公司变更医疗器械生产许可证的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Guangzhou Yangpu Medical Technology Co., Ltd. regarding a change in the medical device production license of its subsidiary. It details the updated license information, including the addition of a new product (medical surgical masks) to the production scope. The document is short (1048 characters) and serves as a formal notification of a regulatory update rather than a financial report or detailed operational report. It does not contain financial statements, management discussion, or audit information. It is not a report itself but an announcement of a regulatory change. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2020-02-10 Chinese
关于子公司获得医疗器械注册证的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement from Guangzhou Yangpu Medical Technology Co., Ltd. regarding its subsidiary obtaining a medical device registration certificate. It includes details about the product, registration number, validity period, and regulatory approval. The document is short (1320 characters) and focuses on regulatory approval information rather than financial data or management discussion. It does not contain financial statements, earnings data, or detailed management analysis. It is not a report or presentation but an official announcement about a regulatory milestone. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2020-02-10 Chinese
股价异动的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding abnormal stock price fluctuations for Guangzhou Yangpu Medical Technology Co., Ltd. It details the company's investigation and explanation of the stock price movements, confirms no undisclosed material information, and provides risk warnings related to the COVID-19 pandemic impact on the company. There are no financial statements, no quarterly or annual report data, no audit information, no management changes, no voting results, or other report types. The document is a regulatory announcement about stock price abnormality and related disclosures, fitting the category of a general regulatory filing rather than a financial report or other specific filing type.
2020-02-07 Chinese
股价异动的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement regarding abnormal stock price fluctuations of Guangzhou Yangpu Medical Technology Co., Ltd. It explains the reasons behind the stock price movements, including the impact of the COVID-19 pandemic and company responses. It includes statements about the absence of undisclosed material information and confirms compliance with disclosure regulations. There are no financial statements, audit opinions, or detailed financial data presented. The document is a regulatory announcement about stock price abnormality and related company clarifications, not a financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS). The document length is short (1921 characters), and it is not a report publication announcement or certification letter but a regulatory disclosure.
2020-02-05 Chinese

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.